5-1411297-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001044.5(SLC6A3):​c.1215A>G​(p.Ser405Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.267 in 1,554,866 control chromosomes in the GnomAD database, including 59,254 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.32 ( 8750 hom., cov: 33)
Exomes 𝑓: 0.26 ( 50504 hom. )

Consequence

SLC6A3
NM_001044.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -6.82

Publications

88 publications found
Variant links:
Genes affected
SLC6A3 (HGNC:11049): (solute carrier family 6 member 3) This gene encodes a dopamine transporter which is a member of the sodium- and chloride-dependent neurotransmitter transporter family. The 3' UTR of this gene contains a 40 bp tandem repeat, referred to as a variable number tandem repeat or VNTR, which can be present in 3 to 11 copies. Variation in the number of repeats is associated with idiopathic epilepsy, attention-deficit hyperactivity disorder, dependence on alcohol and cocaine, susceptibility to Parkinson disease and protection against nicotine dependence.[provided by RefSeq, Nov 2009]
SLC6A3 Gene-Disease associations (from GenCC):
  • classic dopamine transporter deficiency syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • SLC6A3-related dopamine transporter deficiency syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • parkinsonism-dystonia, infantile
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BP6
Variant 5-1411297-T-C is Benign according to our data. Variant chr5-1411297-T-C is described in ClinVar as Benign. ClinVar VariationId is 199052.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-6.82 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.498 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC6A3NM_001044.5 linkc.1215A>G p.Ser405Ser synonymous_variant Exon 9 of 15 ENST00000270349.12 NP_001035.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC6A3ENST00000270349.12 linkc.1215A>G p.Ser405Ser synonymous_variant Exon 9 of 15 1 NM_001044.5 ENSP00000270349.9
SLC6A3ENST00000713696.1 linkc.1080A>G p.Ser360Ser synonymous_variant Exon 8 of 15 ENSP00000519000.1
SLC6A3ENST00000713697.1 linkn.*141-1448A>G intron_variant Intron 9 of 10 ENSP00000519001.1

Frequencies

GnomAD3 genomes
AF:
0.317
AC:
48154
AN:
151976
Hom.:
8740
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.504
Gnomad AMI
AF:
0.233
Gnomad AMR
AF:
0.202
Gnomad ASJ
AF:
0.213
Gnomad EAS
AF:
0.113
Gnomad SAS
AF:
0.172
Gnomad FIN
AF:
0.246
Gnomad MID
AF:
0.259
Gnomad NFE
AF:
0.273
Gnomad OTH
AF:
0.278
GnomAD2 exomes
AF:
0.231
AC:
37638
AN:
162704
AF XY:
0.228
show subpopulations
Gnomad AFR exome
AF:
0.505
Gnomad AMR exome
AF:
0.141
Gnomad ASJ exome
AF:
0.227
Gnomad EAS exome
AF:
0.111
Gnomad FIN exome
AF:
0.254
Gnomad NFE exome
AF:
0.267
Gnomad OTH exome
AF:
0.250
GnomAD4 exome
AF:
0.261
AC:
366187
AN:
1402772
Hom.:
50504
Cov.:
36
AF XY:
0.259
AC XY:
179099
AN XY:
692308
show subpopulations
African (AFR)
AF:
0.520
AC:
16533
AN:
31788
American (AMR)
AF:
0.149
AC:
5426
AN:
36452
Ashkenazi Jewish (ASJ)
AF:
0.229
AC:
5770
AN:
25206
East Asian (EAS)
AF:
0.0993
AC:
3597
AN:
36222
South Asian (SAS)
AF:
0.173
AC:
13723
AN:
79434
European-Finnish (FIN)
AF:
0.257
AC:
12536
AN:
48692
Middle Eastern (MID)
AF:
0.254
AC:
1447
AN:
5700
European-Non Finnish (NFE)
AF:
0.270
AC:
291871
AN:
1081132
Other (OTH)
AF:
0.263
AC:
15284
AN:
58146
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
15416
30833
46249
61666
77082
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9826
19652
29478
39304
49130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.317
AC:
48202
AN:
152094
Hom.:
8750
Cov.:
33
AF XY:
0.310
AC XY:
23069
AN XY:
74344
show subpopulations
African (AFR)
AF:
0.504
AC:
20912
AN:
41480
American (AMR)
AF:
0.202
AC:
3088
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.213
AC:
740
AN:
3468
East Asian (EAS)
AF:
0.113
AC:
584
AN:
5172
South Asian (SAS)
AF:
0.172
AC:
828
AN:
4826
European-Finnish (FIN)
AF:
0.246
AC:
2603
AN:
10586
Middle Eastern (MID)
AF:
0.262
AC:
77
AN:
294
European-Non Finnish (NFE)
AF:
0.273
AC:
18579
AN:
67952
Other (OTH)
AF:
0.274
AC:
579
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.527
Heterozygous variant carriers
0
1699
3398
5097
6796
8495
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
448
896
1344
1792
2240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.283
Hom.:
15706
Bravo
AF:
0.321
Asia WGS
AF:
0.163
AC:
566
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Classic dopamine transporter deficiency syndrome Benign:2
Sep 21, 2015
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 06, 2016
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
Aug 29, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 19183461, 28176268, 11704422, 15380858, 24211691, 10762168) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
May 21, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Parkinsonism-dystonia, infantile Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
0.057
DANN
Benign
0.50
PhyloP100
-6.8
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6347; hg19: chr5-1411412; COSMIC: COSV54363880; COSMIC: COSV54363880; API